loader
Please Wait
Applying Filters...

Evonik Evonik

X

List of Drug Master Files (JDMF) for IMIPENEM AND CILASTATIN Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Japan (PMDA). Original Data : PMDA Database

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 High Tech Pharm Co. , Ltd. (1)

02 JW Pharmaceutical Corporation (1)

filter

01 Imipenem hydrate (2)

filter

01 South Korea (1)

02 Blank (1)

Flag Country
Digital Content Digital Content
URL Supplier Web Content
219MF10002
2477, Nambusunhwan-ro Seocho-gu, Se...
2012-05-11
2007-01-18
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
304MF10138
12, Cheomdansaneop 6-ro, Daesowon-m...
2022-10-05
2022-10-05
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for 74431-23-5 / Imipenem API manufacturers, exporters & distributors?

Imipenem manufacturers, exporters & distributors 1

77

PharmaCompass offers a list of Imipenem API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Imipenem manufacturer or Imipenem supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Imipenem manufacturer or Imipenem supplier.

PharmaCompass also assists you with knowing the Imipenem API Price utilized in the formulation of products. Imipenem API Price is not always fixed or binding as the Imipenem Price is obtained through a variety of data sources. The Imipenem Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Imipenem

Synonyms

64221-86-9, Imipemide, N-formimidoylthienamycin, Imipenem anhydrous, Tienamycin, Imipenemum

Cas Number

74431-23-5

Unique Ingredient Identifier (UNII)

Q20IM7HE75

About Imipenem

Semisynthetic thienamycin that has a wide spectrum of antibacterial activity against gram-negative and gram-positive aerobic and anaerobic bacteria, including many multiresistant strains. It is stable to beta-lactamases. Clinical studies have demonstrated high efficacy in the treatment of infections of various body systems. Its effectiveness is enhanced when it is administered in combination with CILASTATIN, a renal dipeptidase inhibitor.

IMIPENEM AND CILASTATIN Manufacturers

A IMIPENEM AND CILASTATIN manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of IMIPENEM AND CILASTATIN, including repackagers and relabelers. The FDA regulates IMIPENEM AND CILASTATIN manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. IMIPENEM AND CILASTATIN API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of IMIPENEM AND CILASTATIN manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

IMIPENEM AND CILASTATIN Suppliers

A IMIPENEM AND CILASTATIN supplier is an individual or a company that provides IMIPENEM AND CILASTATIN active pharmaceutical ingredient (API) or IMIPENEM AND CILASTATIN finished formulations upon request. The IMIPENEM AND CILASTATIN suppliers may include IMIPENEM AND CILASTATIN API manufacturers, exporters, distributors and traders.

click here to find a list of IMIPENEM AND CILASTATIN suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

IMIPENEM AND CILASTATIN JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The IMIPENEM AND CILASTATIN Drug Master File in Japan (IMIPENEM AND CILASTATIN JDMF) empowers IMIPENEM AND CILASTATIN API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the IMIPENEM AND CILASTATIN JDMF during the approval evaluation for pharmaceutical products. At the time of IMIPENEM AND CILASTATIN JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of IMIPENEM AND CILASTATIN suppliers with JDMF on PharmaCompass.

IMIPENEM AND CILASTATIN Manufacturers | Traders | Suppliers

IMIPENEM AND CILASTATIN Manufacturers, Traders, Suppliers 1
14

We have 2 companies offering IMIPENEM AND CILASTATIN

Get in contact with the supplier of your choice:

  1. Choongwae Pharma Corporation
  2. High Tech Pharm Co., Ltd
Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Post Enquiry
POST ENQUIRY